CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 8-K Event Material agreement · Unregistered share sale
- 10KSB Other 10KSB
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Other events
- REGDEX Other REGDEX
- 8-K Event Other events
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- DEF 14C Other DEF 14C
- PRER14C Other PRER14C
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14C Other PRE 14C
- 8-K Event Material agreement · Unregistered share sale
- 10QSB Other 10QSB
- 8-K Event Material agreement · Executive or director change
Page 48 of 54 · 1,070 filings